Vitalware Achieves #1 in KLAS Revenue Cycle, Chargemaster Management Category for 2019

VitalCDM’s Disruptive Approach to Mid-Revenue Cycle Management Unseats Legacy Incumbent

Vitalware™, a leading provider of revenue cycle SaaS solutions, today announced its chargemaster management solution, VitalCDM™, ranked first in the Revenue Cycle - Chargemaster Management category of the “2019 Best In KLAS Awards: Software & Services.”

“Receiving this prestigious recognition helps to validate our mission of providing clients with the best chargemaster solution in the industry and is indicative of the marked changes in the industry,” said Kerry Martin, Chief Executive Officer and President of Vitalware. “As more hospitals and health systems strive to drive efficiencies across the mid-revenue cycle while connecting disparate systems, they are increasingly turning to VitalCDM to improve the health of their businesses in an increasingly competitive ecosystem.”

KLAS’s annual report provides unique insight gathered from thousands of healthcare organizations across the country. The report includes client satisfaction scores and benchmark performance metrics, which many provider organizations reference when they select healthcare technology partners. KLAS provides rich, carefully-validated insight from real users to help healthcare providers make more informed technology decisions.

As part of the surveying process, KLAS collected feedback from several Vitalware clients throughout 2018, focusing on areas such as client satisfaction, functionality, implementation, and support.

Implemented in more than 800 hospitals and health systems, VitalCDM is proven to optimize reimbursement, increase operational efficiency and minimize compliance risk. In addition to VitalCDM, hospitals and health systems of all sizes and types rely on Vitalware to deliver optimal results through solutions focusing on price transparency, charge capture, documentation, regulatory code references, coding guidance, process improvement, and education and financial impact.